John S. Montalbano - Dec 1, 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Dec 1, 2022
Transactions value $
$0
Form type
4
Date filed
12/5/2022, 11:30 AM
Previous filing
Mar 4, 2022
Next filing
Nov 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Award $0 +47.2K +8.15% $0.00 627K Dec 1, 2022 Common Shares 47.2K $13.18 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.